Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 4 Planned sale Chief Financial Officer sold 58,629 shares at an average $141.78 ($8,312,294)
  5. 144 Insider Sale of Securities
  6. 4 Planned sale President and CEO sold 125,000 shares at an average $145.92 ($18,240,568)
  7. 4 Gift President and CEO gave 510 shares (gift)
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 4 Planned sale President and CEO sold 100,000 shares at an average $148.91 ($14,890,799)
  10. 144 Insider Sale of Securities
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. S-8 POS Other Post-effective Amendment
  16. S-8 POS Other Post-effective Amendment
  17. S-8 POS Other Post-effective Amendment
  18. S-8 POS Other Post-effective Amendment
  19. S-8 POS Other Post-effective Amendment
  20. S-8 POS Other Post-effective Amendment

Page 1 of 36 · 707 filings